Core Cap Advisors, LLC Biotechnology

Core Cap Advisors, LLC

$2.18 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SAVA Cassava Sciences Inc	$84.2M	$0 0.0% of portfolio	92	Q1 2025 New
COGT Cogent Biosciences, Inc.	$802M	$0 0.0% of portfolio	62	Q1 2025 New
CRNX Crinetics Pharmaceuticals, Inc.	$1.77B	$0 0.0% of portfolio	7	Q1 2025 New
CGEM Cullinan Oncology, Inc.	$354M	$0 0.0% of portfolio	29	Q1 2025 New
DYN Dyne Therapeutics, Inc.	$487M	$0 0.0% of portfolio	47	Q1 2025 Added 571.43%
EDIT Editas Medicine, Inc.	$188M	$0 0.0% of portfolio	115	Q4 2024 Reduced 65.15%
TRDA Entrada Therapeutics, Inc.	$200M	$0 0.0% of portfolio	48	Q1 2025 New
FATE Fate Therapeutics Inc	$112M	$0 0.0% of portfolio	255	Q1 2025 New
GBIO Generation Bio Co.	$30.7M	$0 0.0% of portfolio	946	Q1 2025 Added 127.95%
GERN Geron Corp	$487M	$0 0.0% of portfolio	169	Q1 2025 New
INCY Incyte Corp	$15.3B	$0 0.0% of portfolio	3	Q1 2025 New
INSM Insmed Inc	$14.1B	$0 0.0% of portfolio	9	Q1 2025 New
NTLA Intellia Therapeutics, Inc.	$899M	$0 0.0% of portfolio	29	Q1 2025 New
JAZZ Jazz Pharmaceuticals PLC	$7.2B	$0 0.0% of portfolio	7	Q3 2024 Reduced 46.15%
KURA Kura Oncology, Inc.	$441M	$0 0.0% of portfolio	1	Q1 2025 New
KYMR Kymera Therapeutics, Inc.	$2.54B	$0 0.0% of portfolio	28	Q1 2025 Added 75.0%
MNKD Mannkind Corp	$1B	$0 0.0% of portfolio	63	Q3 2024 Reduced 98.76%
MRVI Maravai Lifesciences Holdings, Inc.	$330M	$0 0.0% of portfolio	322	Q1 2025 New
CDXC Chroma Dex Corp.	$420M	$0 0.0% of portfolio	67	Q1 2025 New
NVAX Novavax Inc	$548M	$0 0.0% of portfolio	143	Q3 2024 New
NRIX Nurix Therapeutics, Inc.	$570M	$0 0.0% of portfolio	51	Q1 2025 New
NUVL Nuvalent, Inc.	$3.68B	$0 0.0% of portfolio	2	Q4 2024 New
NUVB Nuvation Bio Inc.	$487M	$0 0.0% of portfolio	237	Q1 2025 New
OCGN Ocugen, Inc.	$217M	$0 0.0% of portfolio	474	Q1 2025 Added 4,640.0%
OLMA Olema Pharmaceuticals, Inc.	$185M	$0 0.0% of portfolio	249	Q1 2025 Added 260.87%
PEPG Pep Gen Inc.	$28.8M	$0 0.0% of portfolio	546	Q1 2025 Added 74.44%
PLRX Pliant Therapeutics, Inc.	$58.9M	$0 0.0% of portfolio	293	Q1 2025 New
PGEN Precigen, Inc.	$341M	$0 0.0% of portfolio	500	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$304M	$0 0.0% of portfolio	23	Q2 2024 New
RAPT Rapt Therapeutics, Inc.	$303M	$0 0.0% of portfolio	226	Q1 2025 New
SANA Sana Biotechnology, Inc.	$847M	$0 0.0% of portfolio	278	Q4 2024 New
SRPT Sarepta Therapeutics, Inc.	$1.92B	$0 0.0% of portfolio	3	Q1 2025 Reduced 57.14%
SPRO Spero Therapeutics, Inc.	$103M	$0 0.0% of portfolio	50	Q4 2024 Reduced 73.96%
TNGX Tango Therapeutics, Inc.	$604M	$0 0.0% of portfolio	321	Q1 2025 Reduced 57.09%
TSHA Taysha Gene Therapies, Inc.	$117M	$0 0.0% of portfolio	290	Q1 2025 Reduced 23.68%
TGTX Tg Therapeutics, Inc.	$5.69B	$0 0.0% of portfolio	18	Q1 2025 New
TBPH Theravance Biopharma, Inc.	$776M	$0 0.0% of portfolio	27	Q1 2025 New
THRD Third Harmonic Bio, Inc.	$219M	$0 0.0% of portfolio	123	Q1 2025 New
TCRX T Scan Therapeutics, Inc.	$32.4M	$0 0.0% of portfolio	166	Q1 2025 New
TYRA Tyra Biosciences, Inc.	$408M	$0 0.0% of portfolio	16	Q4 2024 New
PCVX Vaxcyte, Inc.	$2.22B	$0 0.0% of portfolio	8	Q4 2024 New
VKTX Viking Therapeutics, Inc.	$2.23B	$0 0.0% of portfolio	29	Q1 2025 Reduced 17.14%
WVE Wave Life Sciences Ltd.	$601M	$0 0.0% of portfolio	24	Q1 2025 New
YMAB Y M Abs Therapeutics, Inc.	$189M	$0 0.0% of portfolio	46	Q1 2025 New
ZNTL Zentalis Pharmaceuticals, Inc.	$82.1M	$0 0.0% of portfolio	167	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.